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Abstract. Renal cell carcinoma is the most common and the most lethal type of kidney cancer with the highest 
incidence in developed countries. At the moment of diagnosis, many patients already have developed metastases. 
Tobacco smoking, obesity, hypertension and occupational exposure are established risk factors. Superoxide dismutase 
(SOD), catalase (CAT) and glutathione peroxidase (GPx) are antioxidant enzymes (AOE) that have a key role in 
protecting from reactive oxygen species (ROS) produced in pathological processes. We examined the antioxidant 
capacity of tumour tissue in patients with clear cell type of renal cell carcinoma. The results showed a significant 
decrease of AOE activities in the tumour tissue compared to the normal kidney tissue, indicating that the tumour tissue 
is under permanent oxidative stress. Renal cell carcinoma is highly resistant to radiation therapy, which is also 
associated with free radical production. Since the tumour tissue has impaired AO capacity, the findings of this study 
may contribute to the improvement of the potential therapeutic treatments. 
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1. INTRODUCTION 
The majority of neoplastic changes in kidneys 
belong to renal cell carcinoma (RCC) (almost 90%). 
Predominant histological form of this cancer is clear 
cell or conventional type which accounts for 75% of all 
cases. Clear cell RCC arises from epithelial cells of the 
proximal tubules. Their active role in reabsorption and 
secretion makes them vulnerable to the effects of 
potential carcinogens. This is in accordance with data 
that only 2% of all cases have hereditary basis [1].  
Renal cell carcinoma is an asimptomatic disease 
with frequent metastases, highly resistant to radiation 
therapy and standard chemotherapy [2]. Established 
risk groups are active or passive smokers, obese 
people, people with hypertension and those who are 
exposed to carcinogenic compounds such as arsenic or 
cadmium.  Patients with end stage of renal disease 
(ESRD) or acquired cystic kidney disease (ACKD) are 
also under the risk [3]. Incidence rates are higher in 
Europe, North America, and Australia, compared to 
Asia, while are the lowest in Africa [4,5].  
Reactive oxygen species (ROS) have a role as 
signalling molecules in process of redox regulation.  
Physiological level of ROS, which is essential to 
accomplish this role, is maintained by antioxidant 
enzymes (AOE). Superoxide dismutases (SODs) 
catalyze reduction of superoxide anion (O2.-) to 
hydrogen peroxide (H2O2). Hydrogen peroxide is a 
substrate for catalase (CAT) and glutathione 
peroxidase family (GPx) that reduce H2O2 into water 
thus preventing Fenton’s reaction [6]. Impaired 
activity of AO enzymes may lead to excessive 
production of ROS and consequently to different 
disorders. 
The relationship between cancer and antioxidants 
is in the scientific focus for many years. The main 
reason is a dual role of antioxidants in neoplastic 
disorders. Antioxidants can suppress carcinogenesis by 
ROS elimination, but also to promote it by allowing the 
survival of metabolically changed cells [7]. In this 
study, we examined the antioxidant status of tumour 
tissue in patients with clear cell type of renal cell 
carcinoma. 
2. METHODS 
Subjects. The study was conducted on 16 patients 
with clear cell type of RCC who underwent radical 
nephrectomy. Tumour tissue specimens were obtained 
after the surgery. Normal tissue samples were taken 
from distant part of the same kidney. All tumour tissue 
samples were examined by a clinical pathologist at the 
Medical Faculty, University of Belgrade and classified 
as grade II by Fuhrman grading system. The study was 
approved by the Ethics Committee of Medical Faculty, 
University of Belgrade and Ethics Committee of 
Clinical Center “Dr Dragiša Mišović-Dedinje“. 
Informed consent was obtained from every patient. 
Tissue samples were washed in saline solution, then 
homogenized in phosphate buffer (0.05 mM KH2PO4 
and 0.1 mM EDTA, pH 7.4) and frozen at -700C for 20h 
to disrupt cell membranes. Thawed homogenates are 
vortexed for 1 min and centrifuged at 10 000 × g, for 15 
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minutes at 40C. The upper aqueous layer was collected 
and used for enzyme activity assays. Enzyme activities 
were expressed as units per milligram of protein 
(U/mg). For the protein concentration measurement, 
we used PierceTM BCA Protein Assay Kit (Thermo 
Fisher Scientific, Inc., Waltham, MA, USA). 
Enzyme assays. Measurement of SOD and GPx 
activity is performed by using commercial kits, 
Superoxide Dismutase Assay Kit (Cayman Chemical, 
Ann Arbor, MI, USA) and Oxis Bioxytech® GPx-340 
(Oxis International, Inc., Portland, OR, USA). Catalase 
activity is measured by the method of Beutler [8].  
Statistics. GraphPad Prism (San Diego, CA, USA) 
software was used for statistical analysis. The 
significance in enzyme activities between normal and 
tumour tissue was determined using a paired t-test. 
3. RESULTS 
Total SOD activity in normal and tumour kidney 
tissue is presented in Figure 1. We found a significantly 
decreased SOD activity in tumour tissue compared 
with the normal kidney tissue (p<0.001). The catalase 
activity is shown in Figure 2. Unlike the normal kidney 
tissue, tumour tissue had dramatically impaired CAT 
activity (p<0.001). A similar pattern was observed for 
glutathione peroxidase activity (Figure 3). Tumour 
tissue showed a significantly decreased GPx activity in 





















Figure 1. Total SOD activity in normal and tumour kidney 
tissue of patients with clear cell RCC. Activity is expressed as 
Units per milligram protein (U/mg). Significance: *** 


















Figure 2. CAT activity in normal and tumour kidney tissue of 
patients with clear cell RCC. Activity is expressed as Units per 





















Figure 3. GPx activity in normal and tumour kidney tissue of 
patients with clear cell RCC. Activity is expressed as Units per 
milligram protein (U/mg). Significance: *** p<0.001 (paired 
t-test) 
4. DISCUSSION 
Oxidative stress may contribute to malignant 
transformation of normal cells as well as to 
proliferation of malignant cells. In this study, we 
examined the activities of SOD, CAT and GPx as the 
first defence line against oxidative stress. 
We observed a significant fall of SOD activity in 
tumour tissue of the kidney in patients with clear cell 
type of RCC which implies that malignant tissue has a 
lower ability to eliminate superoxide anion radical  
(O2-). In previous study, a decreased activity of total 
SOD was also observed [9]. Opposite to these results, 
Ganesamoni et al. [10] found the increased activity of 
SOD in tumour tissue compared to normal kidney 
tissue. 
Decreased activity of CAT in tumour tissue, in our 
study, correlates with the lower expression of this 
enzyme in the clear cell type of RCC found by Soini et 
al. [11]. Same authors also observed a positive 
expression of AO enzymes in normal kidney tissue 
which corresponds to higher activity of these enzymes 
recorded in our study. We observed significantly lower 
 
155 
activity of GPx in tumour tissue and this finding is in 
accordance with previous reports [9,12]. The impaired 
activity of CAT and GPx, the enzymes that have a role 
to eliminate H2O2 and organic peroxides, may increase 
lipid peroxidation caused by oxidative stress. Excessive 
production of superoxide anion radical as a result of 
lower SOD activity could be an additional factor that 
contributes to lipid peroxidation. Increased lipid 
peroxidation is proposed as a potential molecular 
pathway for the increased risk of renal cell carcinoma 
[13]. Gago-Dominguez and Castealao [14] hypothesized 
that apoptosis induced by lipid peroxidation could be 
responsible for the loss of function of VHL gene. The 
VHL gene is a tumour suppressor gene and the 
majority of patients with sporadic (non-inherited) clear 
cell RCC have acquired dysfunction of VHL protein 
[15]. 
In conclusion, our results show a low antioxidant 
capacity of the tumour tissue in clear cell RCC. 
Decreased enzyme activity suggests that tumour tissue 
is under permanent oxidative stress which may be a 
contributing factor in RCC initiation and development. 
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